This document provides an agenda and summaries of recent developments in aging research and clinical trials presented by Bill Faloon:
1. Recent findings from studies on stem cells, drugs like rapamycin and metformin, and combination therapies that have significantly extended lifespan in animals and reduced biomarkers of aging and disease.
2. Large grants and donations totaling over $100 million to fund dog aging studies, trials on long-lived families, and stem cell research indicating increased support and optimism in the field.
3. Reviews of studies published in late 2019 showing that intermittent fasting regimens can improve health, reduce disease, and potentially extend lifespan in humans and animals through effects on cellular pathways and metabolism.